Epidemiological studies have revealed a relationship between PON1 polymorphisms implicated in the different types of cancer development and reduction in serum PON1 activities, such as lung, colorectal, prostate, and breast cancer, among others [157,308,309,310,311]. Here, PON1 is linked to breast cancer.